Clinical Trials Logo
  1. Home
  2. Post-Herpetic Neuralgia
  3. NCT00159666

Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia

Post-Herpetic Neuralgia Clinical Trial

Official title:
A Double-Blind Randomized Placebo-Controlled Trial of the Time to Onset of Pain Relief in Subjects With Post Therapeutic Neuralgia (PHN) Treated With Pregabalin (150 - 600 Mg/Day Flexible Optimized Dose or 300 Mg/Day Fixed Dose) or Placebo

Clinical Trial Summary

The purpose of this study is to measure how rapidly pregabalin treatment can relieve pain in patients with post-herpetic neuralgia

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00159666
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 4
Start date October 2004
Completion date June 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT01944150 - Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis N/A
Completed NCT00305357 - Evolution of Pain From Herpes Zoster
Not yet recruiting NCT03120962 - Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia N/A
Completed NCT02701374 - Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia Phase 2
Terminated NCT03094195 - Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN) Phase 2
Completed NCT02318719 - DS-5565 Phase III Study for Post-herpetic Neuralgia N/A
Completed NCT01752699 - Methadone in Post-Herpetic Neuralgia Pain Phase 3
Completed NCT01250561 - Reduction of Postherpetic Neuralgia in Herpes Zoster N/A
Completed NCT02607280 - DS-5565 Phase III Study for Renal Impairment in Japanese Subjects Phase 3
Completed NCT01037088 - Effects of Vaporized Marijuana on Neuropathic Pain Phase 1/Phase 2
Completed NCT02633306 - Transcranial Magnetic Stimulation for Facial Pain N/A
Recruiting NCT05593237 - Transcranial Magnetic Stimulation for Chronic Neuropathic Pain N/A
Completed NCT01848730 - Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia Phase 2